KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Non-Current Deffered Revenue (2016 - 2017)

Astrana Health (ASTH) has disclosed Non-Current Deffered Revenue for 3 consecutive years, with $683504.0 as the latest value for Q3 2017.

  • Quarterly Non-Current Deffered Revenue fell 16.58% to $683504.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $683504.0 through Sep 2017, down 16.58% year-over-year, with the annual reading at $747418.0 for FY2017, 2.54% up from the prior year.
  • Non-Current Deffered Revenue hit $683504.0 in Q3 2017 for Astrana Health, down from $715462.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $819375.0 in Q3 2016 to a low of $11610.0 in Q1 2015.
  • Historically, Non-Current Deffered Revenue has averaged $662599.0 across 3 years, with a median of $728877.0 in 2016.
  • Biggest five-year swings in Non-Current Deffered Revenue: surged 6178.01% in 2016 and later fell 16.58% in 2017.
  • Year by year, Non-Current Deffered Revenue stood at $680336.0 in 2015, then rose by 19.7% to $814348.0 in 2016, then dropped by 16.07% to $683504.0 in 2017.
  • Business Quant data shows Non-Current Deffered Revenue for ASTH at $683504.0 in Q3 2017, $715462.0 in Q2 2017, and $747418.0 in Q1 2017.